VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
HWKN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HWKNHawkins, Inc.
$150.95$3.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksHWKNFinancials

Hawkins, Inc. (HWKN) Income Statement

30Y historyFree accessUpdated daily

Revenue growth of 11.9% on $313.8M in 2027Q2 with gross margin rebounding 400 basis points to 24.4% suggests seasonal normalization, though SG&A rising 31% versus 27% gross profit growth and operating margin remaining at 13.4% versus 15.6% two years ago implies limited operating leverage.

Income StatementBalance SheetCash FlowRatios

HWKN Income Statement

Annual statement

HWKN Income Statement

Hawkins, Inc. (HWKN) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMMar'26Mar'25Mar'24Apr'23Apr'22Mar'21Mar'20Mar'19Apr'18Apr'17Apr'16Mar'15Mar'14Mar'13Apr'12Apr'11Mar'10Mar'09Mar'08Apr'07Apr'06Apr'05Mar'04Mar'03Sep'01Oct'00Oct'99Sep'98Sep'97Sep'96
Sales/Revenue1.14B1.08B974.43M919.16M935.1M774.54M596.87M540.2M556.33M504.17M483.59M413.98M364.02M348.26M350.39M343.83M297.64M257.1M284.36M186.66M160.41M143.33M115.28M107.03M104M107.93M98.02M96.7M94.7M87.7M80.9M
Revenue Growth %9.02%11.21%6.01%-1.7%20.73%29.77%10.49%-2.9%10.35%4.25%16.82%13.72%4.53%-0.61%1.91%15.52%15.77%-9.59%52.34%16.37%11.91%24.33%7.71%2.91%-3.64%10.11%1.37%2.11%7.98%8.41%-2.88%
Cost of Goods Sold883.82M859.94M761.69M725.53M769.98M628.02M473.11M439.28M460.39M417.41M385.52M333.72M298.23M286.66M293.45M277.97M235.74M192.65M221.94M148.14M123.17M110.11M85.67M79.05M76.05M83.63M73.22M72.8M70.4M64.7M61.3M
COGS % of Revenue-79.35%78.17%78.93%82.34%81.08%79.26%81.32%82.76%82.79%79.72%80.61%81.93%82.31%83.75%80.84%79.2%74.93%78.05%79.36%76.79%76.82%74.32%73.86%73.12%77.49%74.7%75.28%74.34%73.77%75.77%
Gross Profit255.66M223.75M212.74M193.64M165.12M146.52M123.76M100.92M95.94M86.76M98.07M80.26M65.79M61.6M56.94M65.87M61.9M64.44M62.42M38.53M37.24M33.22M29.61M27.97M27.96M24.3M24.8M23.9M24.3M23M19.6M
Gross Margin %22.44%20.65%21.83%21.07%17.66%18.92%20.74%18.68%17.24%17.21%20.28%19.39%18.07%17.69%16.25%19.16%20.8%25.07%21.95%20.64%23.21%23.18%25.68%26.14%26.88%22.51%25.3%24.72%25.66%26.23%24.23%
Gross Profit Growth %-5.18%9.86%17.27%12.69%18.39%22.64%5.19%10.58%-11.54%22.2%21.99%6.8%8.19%-13.56%6.41%-3.95%3.24%62.01%3.47%12.09%12.2%5.83%0.06%15.06%-2.03%3.77%-1.65%5.65%17.35%2.62%
Operating Expenses134.19M108.64M92.19M89.6M76.97M75.33M67.88M59.25M59.12M59.4M59.38M49.09M35.38M33.51M31.61M30.76M29.94M25.61M25.08M26.52M25.97M20.46M18.09M19.79M14.89M14.24M11.77M10.8M12.2M11.2M10.4M
OpEx % of Revenue-10.02%9.46%9.75%8.23%9.73%11.37%10.97%10.63%11.78%12.28%11.86%9.72%9.62%9.02%8.95%10.06%9.96%8.82%14.21%16.19%14.27%15.69%18.49%14.32%13.2%12%11.17%12.88%12.77%12.86%
Selling, General & Admin134.19M108.64M92.19M89.6M76.97M75.33M67.88M59.25M59.12M59.4M59.38M49.09M35.38M33.51M31.61M30.76M29.94M25.61M25.08M26.52M25.97M21.51M18.09M16.79M14.89M14.24M11.77M10.8M10.2M9.5M8.9M
SG&A % of Revenue-10.02%9.46%9.75%8.23%9.73%11.37%10.97%10.63%11.78%12.28%11.86%9.72%9.62%9.02%8.95%10.06%9.96%8.82%14.21%16.19%15.01%15.69%15.69%14.32%13.2%12%11.17%10.77%10.83%11%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses0000-334K189K0-204K73K91K000000000000000000000
Operating Income121.47M115.12M120.54M104.04M88.15M71.19M55.88M41.67M36.82M-11.76M38.69M31.17M30.42M28.09M25.33M35.11M31.96M38.84M37.34M12M11.26M12.76M11.52M8.18M13.07M10.06M13.04M13.1M12.1M11.8M9.2M
Operating Margin %10.66%10.62%12.37%11.32%9.43%9.19%9.36%7.71%6.62%-2.33%8%7.53%8.36%8.07%7.23%10.21%10.74%15.11%13.13%6.43%7.02%8.9%9.99%7.64%12.56%9.32%13.3%13.55%12.78%13.46%11.37%
Operating Income Growth %--4.5%15.87%18.02%23.82%27.41%34.09%13.18%413.1%-130.39%24.13%2.48%8.28%10.9%-27.85%9.85%-17.71%4.03%211.04%6.57%-11.74%10.82%40.77%-37.39%29.95%-22.87%-0.49%8.26%2.54%28.26%1.1%
EBITDA176.7M167.66M160.49M135.84M117.56M95.32M78.55M63.26M58.57M10.63M59.57M46.68M43.43M40.7M35.58M43.57M39.11M45.13M42.92M17.25M15.6M16.45M16.04M11.17M16.03M12.78M15.3M15.2M14.1M13.5M10.7M
EBITDA Margin %15.51%15.47%16.47%14.78%12.57%12.31%13.16%11.71%10.53%2.11%12.32%11.28%11.93%11.69%10.15%12.67%13.14%17.55%15.09%9.24%9.73%11.48%13.91%10.44%15.41%11.84%15.6%15.72%14.89%15.39%13.23%
EBITDA Growth %5.94%4.47%18.15%15.55%23.33%21.36%24.18%7.99%450.97%-82.15%27.6%7.49%6.72%14.38%-18.34%11.4%-13.34%5.16%148.76%10.59%-5.16%2.57%43.55%-30.28%25.37%-16.43%0.63%7.8%4.44%26.17%1.9%
D&A (Non-Cash Add-back)55.23M52.54M39.95M31.8M29.41M24.13M22.67M21.58M21.76M22.39M20.88M15.51M13.02M12.61M10.25M8.46M7.15M6.29M5.58M5.25M4.34M3.69M4.52M2.99M2.96M2.73M2.26M2.1M2M1.7M1.5M
EBIT128.18M122.85M119.81M105.43M87.82M71.38M57.32M41.67M36.82M-11.76M38.69M31.17M30.45M28.09M25.33M35.11M31.96M38.84M37.34M12M11.26M12.76M11.52M8.18M13.07M10.06M13.04M13.1M12.1M11.8M9.2M
Net Interest Income-6.28M-13.51M-5.43M-4.28M-5.23M-1.4M-1.47M-2.51M-3.36M-3.41M-2.64M-805K38K-29K84K145K000000000000000
Interest Income00000000000038K084K145K000000000000000
Interest Expense6.28M13.51M5.43M4.28M5.23M1.4M1.47M2.51M3.36M3.41M2.64M805K029K00000000000000000
Other Income/Expense-5.11M-5.78M-6.16M-2.89M-5.57M-1.22M-27K-2.71M-3.29M-3.32M-2.64M-805K38K-29K84K145K333K286K338K1.34M1.69M892.29K1.12M825.69K362.96K700.84K1.04M2.9M1.3M900K1.3M
Pretax Income116.36M109.34M114.38M101.14M82.58M69.98M55.85M38.96M33.53M-15.08M36.05M30.37M30.45M28.06M25.41M35.25M32.3M39.13M37.67M13.35M12.96M13.65M12.64M9.01M13.43M10.76M14.08M16M13.4M12.7M10.5M
Pretax Margin %10.21%10.09%11.74%11%8.83%9.03%9.36%7.21%6.03%-2.99%7.45%7.34%8.37%8.06%7.25%10.25%10.85%15.22%13.25%7.15%8.08%9.53%10.96%8.42%12.91%9.97%14.36%16.55%14.15%14.48%12.98%
Income Tax30.55M27.79M30.04M25.78M22.54M18.44M14.87M10.59M9.1M-5.9M13.49M12.22M11.24M9.97M8.31M13.63M11.98M15.39M14.25M4.86M4.89M4.77M4.55M3.25M5M3.64M5.51M6.3M5.2M4.9M4M
Effective Tax Rate %26.25%25.42%26.26%25.49%27.3%26.35%26.63%27.18%27.13%39.13%37.43%40.25%36.91%35.52%32.68%38.65%37.1%39.33%37.83%36.4%37.72%34.92%35.97%36.14%37.23%33.83%39.15%39.38%38.81%38.58%38.1%
Net Income85.81M81.55M84.34M75.36M60.04M51.54M40.98M28.37M24.43M-9.18M22.55M18.14M19.21M18.09M17.13M22.68M20.31M23.85M23.76M9.11M8.07M8.89M8.09M5.75M8.43M7.12M8.57M9.7M8.2M7.8M6.5M
Net Margin %7.53%7.52%8.66%8.2%6.42%6.65%6.87%5.25%4.39%-1.82%4.66%4.38%5.28%5.2%4.89%6.6%6.83%9.28%8.36%4.88%5.03%6.2%7.02%5.37%8.11%6.59%8.74%10.03%8.66%8.89%8.03%
Net Income Growth %3.23%-3.32%11.92%25.52%16.49%25.77%44.46%16.1%366.24%-140.69%24.32%-5.57%6.19%5.65%-24.51%11.67%-14.82%0.35%160.86%12.9%-9.2%9.81%40.68%-31.77%18.44%-16.93%-11.67%18.29%5.13%20%22.64%
Net Income (Continuing)85.81M81.55M84.34M75.36M60.04M51.54M40.98M28.37M24.43M-9.18M22.55M18.14M19.21M18.09M17.11M21.63M20.31M23.74M23.42M8.49M8.07M8.89M8.09M5.75M8.43M7.12M8.57M9.7M8.2M7.8M6.5M
Discontinued Operations0000000000000018K1.06M0109K340K000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)4.133.914.033.592.862.441.931.331.14-0.431.070.860.910.860.811.090.981.161.160.450.220.440.400.280.420.350.410.440.360.340.28
EPS Growth %3.52%-2.98%12.26%25.52%17.21%26.42%45.11%16.67%365.12%-140.19%24.42%-5.49%5.81%6.17%-25.69%11.22%-15.52%0%157.78%104.55%-50%10%42.86%-33.33%20%-14.63%-6.82%22.22%5.88%21.43%21.74%
EPS (Basic)-3.934.053.612.882.461.951.341.15-0.431.070.860.910.860.821.100.991.171.160.450.400.440.400.280.420.350.410.440.360.340.28
Diluted Shares Outstanding20.78M20.86M20.94M21.01M21.01M21.14M21.26M21.31M21.45M21.29M21.19M21.16M21.27M21.2M21.08M20.82M20.71M20.57M20.5M20.43M20.35M20.42M20.45M20.43M20.43M20.69M21.15M22.3M23.2M23.28M23.68M
Basic Shares Outstanding20.71M20.74M20.8M20.86M20.85M20.95M21.02M21.16M21.31M21.21M21.07M21.05M21.14M21.09M20.93M20.68M20.52M20.5M20.49M20.43M20.34M20.4M20.43M20.43M20.43M20.69M21.15M22.3M23.1M23.28M23.21M
Dividend Payout Ratio-19.21%17.35%17.57%19.99%21.45%24.47%34.64%49.01%-38.5%45.51%40.9%40.95%40.5%28.29%34.48%27.56%21.57%51.71%52.94%43.78%45.54%63.94%36.36%43.82%36.29%28.87%26.83%24.36%24.62%

Key Metrics

Growth RegimeExpanding
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Chlor-alkali input cost volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2027Q2)

Revenue Growth Regains Double-Digit Pace

After opening FY2025 with just 1.9% year-over-year expansion, Hawkins has reaccelerated to 11.9% revenue growth on $313.8M of sales in 2027Q2, the firmest rate since 2026Q1's 14.6% peak, based on Hawkins' ten-quarter income statement history.

The acceleration is not uniform across the calendar: 2026Q3 and 2026Q4 revenue of $244.1M and $265.9M mark the recurring seasonal troughs, while the first half of each fiscal year carries heavier municipal and pool-season volumes, so the underlying trend appears closer to mid-single-digit growth with acquisition contribution layered on top. Investors should decompose the reported 11.9% into price and volume components, since pass-through of higher chlor-alkali costs can inflate headline growth without corresponding unit expansion, and durability of that growth looks more dependent on Water Treatment contract renewals than on Industrial demand.

Gross Margin Recovers From Seasonal Trough

Gross margin rebounded to 24.4% in 2027Q2 from a 20.4% low in 2026Q4, a 400 basis point swing that suggests seasonal and mix effects rather than structural erosion, though the reading still sits below 2025Q1's 25.3%, as reported in the company's quarterly filings.

The consistent 400-500 basis point compression in third and fourth quarters (20.8% and 20.4% in FY2026, 21.4% and 19.8% in FY2025) points to predictable mix deterioration rather than competitive pricing pressure, which supports modeling margins on a full-year rather than quarterly basis. At 24.4%, Hawkins sits roughly 11 points below Balchem's 35.7% but well above Tronox's distressed 7.9%, consistent with a blend of low-margin bulk distribution and higher-value water treatment service; the failure to reclaim the 25.3% peak may indicate some raw material pass-through lag in fixed-price municipal contracts.

Overhead Build Outpaces Gross Profit

On a year-over-year basis, Hawkins' SG&A climbed 31% from $26.5M in 2025Q2 to $34.7M in 2027Q2, slightly outpacing the 27% rise in gross profit, which implies limited operating leverage despite record quarterly revenue, per the company's reported income statements.

Because gross profit grew 27% year over year while operating income advanced only from $34.5M to $41.9M (about 21%), the incremental margin on new business appears thinner than the base, implying the SG&A build is not yet fully absorbed. The step-up from a $23.8M-$27.0M quarterly SG&A range through 2025Q4 to $32.0M-$35.3M from 2026Q1 onward suggests a structurally higher fixed cost base; holding SG&A growth below revenue growth now looks like the swing factor for any further operating margin expansion beyond the current 13.4%.

Below-Line Items Cloud EPS Reversal

Hawkins posted diluted EPS of $1.34 alongside net income of $27.8M in 2027Q2 while stock-based compensation was recorded at -$3.9M, inverting the prior pattern of $1.5M-$2.4M quarterly charges, a sign change that warrants further investigation from the reported statements.

The 4.5 percentage point gap between the 13.4% operating margin and the 8.9% net margin in 2027Q2 reflects taxes and below-the-line items rather than operating weakness, yet it still leaves quarterly net income below 2025Q1's $28.9M despite substantially higher revenue, so earnings quality appears adequate but not improving structurally. Diluted EPS declined year over year for four consecutive quarters through 2027Q1 (-6.9%, -4.2%, -5.1%, -3.6%) before rebounding 24.1%, a pattern consistent with a cyclical rather than structural shortfall, though investors should reconcile the stock-based compensation sign convention and identify any non-recurring items behind the reversal.

Margin Recovery Rests on Unproven Mix

Hawkins' operating margin of 13.4% in 2027Q2 remains 220 basis points below the 15.6% recorded in 2025Q1 despite 22.6% higher revenue, suggesting the recent EPS beat may reflect recovery from a depressed base rather than durable structural improvement, based on the filed income statement history.

The strongest challenge to the current narrative is that the 2027Q2 beat of $1.34 versus $1.18 consensus arrived against a base in which operating margin had already compressed from 15.6% to 7.7% over six quarters, making part of the improvement mean-reversion rather than new earnings power. Compounding this, SG&A has risen roughly 39% across the ten-quarter window and is now embedded regardless of revenue momentum, while the Industrial segment's exposure to bulk chlor-alkali pricing means the 24.4% gross margin could compress again if caustic soda softens; investors should monitor whether the 8.9% net margin can hold above the 5.8%-6.7% range seen in the FY2026 trough.

HWKN — Frequently Asked Questions

Quick answers to the most common questions about buying HWKN stock.

What was Hawkins, Inc.'s (HWKN) revenue in 2026?

For fiscal year 2026, Hawkins, Inc. (HWKN) reported total revenue of $1.08B. This represents a 1239.6% increase compared to $80.9M in 1996.

Is Hawkins, Inc. (HWKN) profitable?

Hawkins, Inc. (HWKN) is profitable, generating $81.5M in net income for the fiscal year ending 2026 with a net profit margin of 7.5%.

What is Hawkins, Inc.'s operating profit margin?

Hawkins, Inc. (HWKN) reported an operating income of $115.1M, resulting in an operating profit margin of 10.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Hawkins, Inc.'s gross profit and gross margin?

Hawkins, Inc. (HWKN) generated $223.8M in gross profit for the year, representing a gross profit margin of 20.6%. This demonstrates the company's core pricing power and production efficiency.